227 related articles for article (PubMed ID: 20223659)
1. Oxazolomycins: natural product lead structures for novel antibacterials by click fragment conjugation.
Bagwell CL; Moloney MG; Yaqoob M
Bioorg Med Chem Lett; 2010 Apr; 20(7):2090-4. PubMed ID: 20223659
[TBL] [Abstract][Full Text] [Related]
2. Studies on the antibacterial action of novel gem-diphenyl-spiro-cyclopropano- oxazolones and 2-aryl(alkyl)-4-ylidene-oxazol-5-ones.
Lalitha N; Annapurna J; Iyengar DS; Bhalerao UT
Arzneimittelforschung; 1991 Aug; 41(8):827-30. PubMed ID: 1781805
[TBL] [Abstract][Full Text] [Related]
3. Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosus.
Manam RR; Teisan S; White DJ; Nicholson B; Grodberg J; Neuteboom ST; Lam KS; Mosca DA; Lloyd GK; Potts BC
J Nat Prod; 2005 Feb; 68(2):240-3. PubMed ID: 15730252
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic synthesis, antibacterial activity and structure-activity properties of the pyroglutamate core of oxazolomycin.
Angelov P; Chau YK; Fryer PJ; Moloney MG; Thompson AL; Trippier PC
Org Biomol Chem; 2012 May; 10(17):3472-85. PubMed ID: 22437843
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems.
Josa-Culleré L; Towers C; Willenbrock F; Macaulay VM; Christensen KE; Moloney MG
Org Biomol Chem; 2017 Jun; 15(25):5373-5379. PubMed ID: 28617490
[TBL] [Abstract][Full Text] [Related]
6. The discovery of biaryl acids and amides exhibiting antibacterial activity against Gram-positive bacteria.
Look GC; Vacin C; Dias TM; Ho S; Tran TH; Lee LL; Wiesner C; Fang F; Marra A; Westmacott D; Hromockyj AE; Murphy MM; Schullek JR
Bioorg Med Chem Lett; 2004 Mar; 14(6):1423-6. PubMed ID: 15006375
[TBL] [Abstract][Full Text] [Related]
7. The oxazolomycins: a structurally novel class of bioactive compounds.
Moloney MG; Trippier PC; Yaqoob M; Wang Z
Curr Drug Discov Technol; 2004 Oct; 1(3):181-99. PubMed ID: 16472256
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
Arumugam N; Periyasami G; Raghunathan R; Kamalraj S; Muthumary J
Eur J Med Chem; 2011 Feb; 46(2):600-7. PubMed ID: 21177001
[TBL] [Abstract][Full Text] [Related]
9. Nontoxic membrane-active antimicrobial arylamide oligomers.
Liu D; Choi S; Chen B; Doerksen RJ; Clements DJ; Winkler JD; Klein ML; DeGrado WF
Angew Chem Int Ed Engl; 2004 Feb; 43(9):1158-62. PubMed ID: 14983462
[No Abstract] [Full Text] [Related]
10. Mimics of pramanicin derived from pyroglutamic acid and their antibacterial activity.
Tan SW; Chai CL; Moloney MG
Org Biomol Chem; 2017 Feb; 15(8):1889-1912. PubMed ID: 28169387
[TBL] [Abstract][Full Text] [Related]
11. Armeniaspiroles, a new class of antibacterials: Antibacterial activities and total synthesis of 5-chloro-Armeniaspirole A.
Couturier C; Bauer A; Rey A; Schroif-Dufour C; Broenstrup M
Bioorg Med Chem Lett; 2012 Oct; 22(19):6292-6. PubMed ID: 22921279
[TBL] [Abstract][Full Text] [Related]
12. Novel bioactive oxazolomycin isomers produced by Streptomyces albus JA3453.
Kanzaki H; Wada K; Nitoda T; Kawazu K
Biosci Biotechnol Biochem; 1998 Mar; 62(3):438-42. PubMed ID: 9571773
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
[TBL] [Abstract][Full Text] [Related]
14. Citreamicins with potent gram-positive activity.
Hopp DC; Milanowski DJ; Rhea J; Jacobsen D; Rabenstein J; Smith C; Romari K; Clarke M; Francis L; Irigoyen M; Luche M; Carr GJ; Mocek U
J Nat Prod; 2008 Dec; 71(12):2032-5. PubMed ID: 19053507
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
[TBL] [Abstract][Full Text] [Related]
16. Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).
Sampson PB; Picard C; Handerson S; McGrath TE; Domagala M; Leeson A; Romanov V; Awrey DE; Thambipillai D; Bardouniotis E; Kaplan N; Berman JM; Pauls HW
Bioorg Med Chem Lett; 2009 Sep; 19(18):5355-8. PubMed ID: 19682901
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
Zhou Y; Sun Z; Froelich JM; Hermann T; Wall D
Bioorg Med Chem Lett; 2006 Oct; 16(20):5451-6. PubMed ID: 16890435
[TBL] [Abstract][Full Text] [Related]
18. Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy.
Singh SB; Zink DL; Dorso K; Motyl M; Salazar O; Basilio A; Vicente F; Byrne KM; Ha S; Genilloud O
J Nat Prod; 2009 Mar; 72(3):345-52. PubMed ID: 19115838
[TBL] [Abstract][Full Text] [Related]
19. 2-Aminotetralones: novel inhibitors of MurA and MurZ.
Dunsmore CJ; Miller K; Blake KL; Patching SG; Henderson PJ; Garnett JA; Stubbings WJ; Phillips SE; Palestrant DJ; Angeles Jde L; Leeds JA; Chopra I; Fishwick CW
Bioorg Med Chem Lett; 2008 Mar; 18(5):1730-4. PubMed ID: 18261901
[TBL] [Abstract][Full Text] [Related]
20. Novel lysine-peptoid hybrids with antibacterial properties.
Ryge TS; Hansen PR
J Pept Sci; 2005 Nov; 11(11):727-34. PubMed ID: 16161020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
